Dr. Sheng Lin-Gibson

Chief of the NIST Biosystems and Biomaterials Division at the National Institute of Standards and Technology, U.S. Department of Commerce

Dr. Sheng Lin-Gibson is the Chief of the NIST Biosystems and Biomaterials Division.  She oversees a multidisciplinary research portfolio that includes regenerative medicine and advanced therapies, precision medicine, synthetic biology, and complex microbial systems. She leads and coordinates the development of global standards for emerging biotechnology, many of which support regenerative medicine and advanced therapy. She has coauthored over 80 peer-reviewed publications, serves on many Interagency Working Groups as well as numerous expert review panels and advisory boards. She has received two Department of Commerce Gold Medals.